Silicon Biosystems
Innovative technologies and solutions for isolation, recovery & molecular characterization of pure, single rare cells..
Launch date
Employees
Market cap
-
Enterprise valuation
AUD42—63m (Dealroom.co estimates Mar 2010.)
Company register number BO0452593
Bologna Emilia-Romagna (HQ)
Financials
Estimates*
| EUR | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 6.6m | 8.3m | 6.3m | 7.5m | 5.3m | 6.3m | 6.0m |
| % growth | - | - | (24 %) | 19 % | (30 %) | 19 % | (4 %) |
| EBITDA | (6.9m) | (14.6m) | (26.3m) | (22.6m) | (18.7m) | (18.2m) | (21.0m) |
| % EBITDA margin | (104 %) | (175 %) | (415 %) | (300 %) | (353 %) | (290 %) | (349 %) |
| Profit | (10.2m) | (43.7m) | (35.7m) | (29.5m) | (28.1m) | (27.0m) | (34.9m) |
| % profit margin | (154 %) | (524 %) | (563 %) | (391 %) | (532 %) | (431 %) | (580 %) |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | €1.5m | Series A | |
$2.7m | Series B | ||
€300k | Grant | ||
| N/A | $6.8m | Early VC | |
N/A | Acquisition | ||
| Total Funding | AUD17.8m | ||
Related Content
Recent News about Silicon Biosystems
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.